ImmunityBio (IBRX) announced the Medicines and Healthcare products Regulatory Agency has validated and accepted the marketing authorization ...

Dr Scott Tagawa discusses how dose adjustments can optimize the use of enfortumab vedotin in urothelial cancer.

BlipCut, a leading innovator in video translation and localization, is excited to announce its integration of the DeepSeek model to enhance translation rewriting capabilities. The integration of ...

Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced a grant through the Apotex Global Health Access Fund to Healthy Mothers, Healthy Babies Coalition of Broward ...

"I never thought I’d live this long." Terry Bradshaw once said those words with a laugh, but deep down, there was truth to ...

MRI for the initial staging of MIBC is both feasible and beneficial in reducing treatment delays compared to TURBT, a new study shows.